Evidence supporting the use of: 1,3,7-Trimethylpurine-2,6-dione
For the health condition: Migraine

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 4

1,3,7-Trimethylpurine-2,6-dione is the chemical name for caffeine. Its use in the treatment or support of migraine is scientifically validated and is included in several evidence-based clinical guidelines. Multiple clinical studies have demonstrated that caffeine, when used in combination with common analgesics such as acetaminophen or aspirin, can enhance their efficacy in relieving migraine attacks. The mechanism involves caffeine's antagonism of adenosine receptors, leading to vasoconstriction of cerebral blood vessels, which can counteract the vasodilation associated with migraine headaches. Additionally, caffeine’s ability to increase the absorption and potency of certain pain medications contributes to its therapeutic effect.

Several over-the-counter and prescription migraine medications (e.g., Excedrin Migraine) contain caffeine for this reason. The American Headache Society and other professional organizations recognize caffeine as an effective adjunct in the acute treatment of migraine. However, it is worth noting that excessive or chronic use of caffeine can lead to medication overuse headache or withdrawal headache in some individuals. Thus, while there is robust scientific evidence for its use as an acute migraine treatment, guidelines typically recommend moderation and caution against chronic daily use.

In summary, caffeine’s role in migraine management is well-supported by scientific literature, primarily as an adjuvant to analgesics for acute relief, rather than as a standalone or preventive therapy.

More about 1,3,7-Trimethylpurine-2,6-dione
More about Migraine

Products containing 1,3,7-Trimethylpurine-2,6-dione

We currently have no products on Vitabase that contain this ingredient.